Article
Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs).
Research Center for Anti-Infective Drugs, Kitasato Institute, Minato-ku, Tokyo, Japan.
Journal of Infection and Chemotherapy (impact factor:
1.8).
01/2008;
13(6):390-5.
DOI:10.1007/s10156-007-0563-2
pp.390-5
Source: PubMed
-
Citations (0)
-
Cited In (0)
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
AmpC
beta-lactamases
buffer solution
chemical structure
derepressed AmpC
enzymatic characteristics
enzymatic reactivities
ESBLs
extended-spectrum beta-lactamases
kinetic parameters
Km values
maximum velocity
MBL
metallo beta-lactamase
metallo-beta-lactamases
Michaelis constant
new chromogenic cephalosporin
smaller
two entities